“Sticking With MSA” -Dr. Wouter Peelearts (Researcher, Michigan)
Sticking with Multiple System Atrophy
Multiple System Atrophy (MSA) is a rare brain disorder that until recently was largely ignored by the research community. MSA is a rapidly progressing neurodegenerative disease caused by a decline of the body’s most basic and vital functions including breathing, digestion, urination, controlling blood pressure and movement.
3rd ANNUAL VIRTUAL MSA CONFERENCE – SEPTEMBER & FREE
MISE À JOUR DES NOUVELLES DE LA RECHERCHE 2022
PROMISING NEW RESEARCH FUNDED 2022
#defeatmsa #kickmsa #MSAresearch #newresearch #MultipleSystemAtrophy #msaunited #Consortium Help Us - Fund Research Now! Choose A Charity in Our Consortium: www.msaunited.org
MSA United Research Consortium Advisors
HELP DEFEAT MSA! Donate to A Consortium Partner: Defeat MSA Alliance - USA Defeat MSA/Vaincre AMS Canada Defeat MSA Australia and New Zealand, Ltd. (AU-NZ) Combattiamo AMS/MSA Italia Asociación Española Síndrome Shy Drager – Atrofia Multisistémica * Promising...
“On the Importance of showing up & trying” – By Kimberly Bohannon
Kimberly S. Bohannon was a caregiver to her husband Steve, who passed from MSA at the age of 49. She regularly writes about her experiences in a blog on Medium. Today, for the first time, we share an excerpt from Kimberly’s blog about caring for her husband. Are you...
HAPPY NEW YEAR FROM ALL OF US!
HAPPY NEW YEAR!! May this year increase your hope and happiness! Let’s go forward together to Defeat MSA forever! We thank you for your continued support! www.msacanada.ca/donate-to-us/ #defeatmsa #kickmsa
Lundbeck Launches Phase 2 Study for MSA
Good news from Lundbeck! The company plans to initiate Phase 2 Study for Potential Treatment for Multiple System Atrophy! --- Press Release (Mon, Nov 08, 2021 09:00 CET) H. Lundbeck A/S (Lundbeck), announces that it has expanded its clinical-stage pipeline and is...
GIVE THE GIFT OF AWARENESS THIS HOLIDAY!
GIVE AWARENESS FOR THE HOLIDAYS! Help Us Defeat MSA Now! CANADA STORE: https://www.msacanada.ca/shop/
Alterity reports additional support for ATH 434
ALTERITY PRESS RELEASE: MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 4 November 2021: Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative...
LOOKING FOR OTHER WAYS TO GET INVOLVED?
JOIN THE MOVEMENT TO #DEFEATMSA
Follow us on social media
Follow us on Twitter
Follow us on Facebook
Follow us on Instagram
Follow us on YouTube
Follow us on social media
Follow us on LinkedIn
Resources & Downloads
Overview MSA Treatments (EN)
Known Treatments AMS (FR)
MSA Virtual Conf - 2021
MSA Virtual Conf - 2022
Researcher & Mission Blogs
Charity Brochure (English)
Charity Brochure (French)
Patient Brochure (English)
Patient Brochure (French)
MSA Awareness Stickers
Patient Card (English)
Patient Card (French)
Awareness Card (US Edition)
CREATEDBY | RIOSMEDIA